Ann: Appointment of Non-Executive Director and Appendix 3X, page-36

I should add im curious to know how genentech research is progressing and exactly how they are planning to use the tech. One problem with fpp seems to be how you put enough into the body intravenously so it can actually reach the cells you target. I am wondering if their intention is along the lines of locally treating wound sites or infection areas with their antibiotics and fpp to allow penetration of cells. This to me sound like a much more near term application for fpp especially in light of the growing resistance to current antibiotic treatments